Whitehawk Therapeutics, Inc. (WHWK)
4.05
-0.15
(-3.57%)
USD |
NASDAQ |
Sep 21, 16:00
4.05
0.00 (0.00%)
After-Hours: 20:00
Whitehawk Therapeutics Total Liabilities (Quarterly) : 11.07M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.07M |
| March 31, 2026 | 11.06M |
| December 31, 2025 | 14.63M |
| September 30, 2025 | 9.849M |
| June 30, 2025 | 8.756M |
| March 31, 2025 | 12.27M |
| December 31, 2024 | 18.23M |
| September 30, 2024 | 16.83M |
| June 30, 2024 | 22.83M |
| March 31, 2024 | 20.61M |
| December 31, 2023 | 27.23M |
| September 30, 2023 | 21.46M |
| June 30, 2023 | 19.81M |
| March 31, 2023 | 24.67M |
| December 31, 2022 | 25.86M |
| September 30, 2022 | 25.00M |
| June 30, 2022 | 19.91M |
| March 31, 2022 | 17.69M |
| December 31, 2021 | 21.50M |
| Date | Value |
|---|---|
| September 30, 2021 | 17.85M |
| June 30, 2021 | 2.208M |
| March 31, 2021 | 2.129M |
| December 31, 2020 | 31.26M |
| September 30, 2020 | 2.512M |
| June 30, 2020 | 3.115M |
| March 31, 2020 | 2.694M |
| December 31, 2019 | 3.401M |
| September 30, 2019 | 3.837M |
| June 30, 2019 | 3.884M |
| March 31, 2019 | 4.261M |
| December 31, 2018 | 5.457M |
| September 30, 2018 | 3.645M |
| June 30, 2018 | 21.63M |
| March 31, 2018 | 3.623M |
| December 31, 2017 | 3.592M |
| September 30, 2017 | 2.586M |
| June 30, 2017 | 1.857M |
| March 31, 2017 | 2.97M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 193.99M |
| Shareholders Equity (Quarterly) | 182.92M |
| Current Ratio | 17.38 |